Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ravi Mangal Patel

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Acta Paediatrica (Oslo, Norway : 1992)|January 24, 2017
Does early treatment with inhaled budesonide prevent death or bronchopulmonary dysplasia in extremely preterm infants?Ravi Mangal Patel
Acta Paediatrica (Oslo, Norway : 1992)|January 26, 2017
Does fluconazole prophylaxis reduce death or invasive candida infection in extremely preterm infants?Ravi Mangal Patel
American Journal of Perinatology|January 23, 2016
Short- and Long-Term Outcomes for Extremely Preterm InfantsRavi Mangal Patel
Pediatrics|December 16, 2020
Probiotics for Preterm Infants: Which One(s) to Choose?Ravi Mangal Patel, Mohan Pammi
Seminars in Fetal & Neonatal Medicine|November 10, 2020
Caffeine for preterm infants: Fixed standard dose, adjustments for age or high dose?Vivek Saroha, Ravi Mangal Patel
Seminars in Perinatology|December 16, 2021
The center-effect on outcomes for infants born at less than 25 weeksNitya Nair, Ravi Mangal Patel
Current Opinion in Hematology|September 11, 2019
Neonatal and pediatric platelet transfusions: current concepts and controversiesRavi Mangal Patel, Cassandra Josephson
Clinics in Perinatology|October 22, 2023
Blood Donor Sex and Outcomes in Transfused InfantsAnand Salem, Ravi Mangal Patel
Clinics in Perinatology|October 22, 2023
Understanding the WHEN, WHAT, and WHY of Neonatal Transfusion MedicineRavi Mangal Patel, Amy Keir
Clinics in Perinatology|February 19, 2013
Therapeutic use of prebiotics, probiotics, and postbiotics to prevent necrotizing enterocolitis: what is the current evidence?Ravi Mangal Patel, Patricia Wei Denning
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Acta Paediatrica (Oslo, Norway : 1992)|January 24, 2017
Does early treatment with inhaled budesonide prevent death or bronchopulmonary dysplasia in extremely preterm infants?Ravi Mangal Patel
Acta Paediatrica (Oslo, Norway : 1992)|January 26, 2017
Does fluconazole prophylaxis reduce death or invasive candida infection in extremely preterm infants?Ravi Mangal Patel
American Journal of Perinatology|January 23, 2016
Short- and Long-Term Outcomes for Extremely Preterm InfantsRavi Mangal Patel
Pediatrics|December 16, 2020
Probiotics for Preterm Infants: Which One(s) to Choose?Ravi Mangal Patel, Mohan Pammi
Seminars in Fetal & Neonatal Medicine|November 10, 2020
Caffeine for preterm infants: Fixed standard dose, adjustments for age or high dose?Vivek Saroha, Ravi Mangal Patel
Seminars in Perinatology|December 16, 2021
The center-effect on outcomes for infants born at less than 25 weeksNitya Nair, Ravi Mangal Patel
Current Opinion in Hematology|September 11, 2019
Neonatal and pediatric platelet transfusions: current concepts and controversiesRavi Mangal Patel, Cassandra Josephson
Clinics in Perinatology|October 22, 2023
Blood Donor Sex and Outcomes in Transfused InfantsAnand Salem, Ravi Mangal Patel
Clinics in Perinatology|October 22, 2023
Understanding the WHEN, WHAT, and WHY of Neonatal Transfusion MedicineRavi Mangal Patel, Amy Keir
Clinics in Perinatology|February 19, 2013
Therapeutic use of prebiotics, probiotics, and postbiotics to prevent necrotizing enterocolitis: what is the current evidence?Ravi Mangal Patel, Patricia Wei Denning
Pageof 5